...
首页> 外文期刊>European journal of preventive cardiology >Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients
【24h】

Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients

机译:在未选择的患者中,基于胱抑素C的肾小球滤过率与基于肌酐或联合肾小球滤过率方程的死亡率更相关

获取原文
获取原文并翻译 | 示例
           

摘要

Background Decreased glomerular filtration rate (GFR) is an important cardiovascular risk factor, but estimated GFR (eGFR) may differ depending on whether it is based on creatinine or cystatin C. A combined creatinine/cystatin C equation has recently been shown to best estimate GFR; however, the benefits of using the combined equation for risk prediction in routine clinical care have been less studied. This study compares mortality risk prediction by eGFR using the combined creatinine/cystatin C equation (CKD-EPI), a sole creatinine equation (CKD-EPI) and a sole cystatin C equation (CAPA), respectively, using assays that are traceable to international calibrators.
机译:背景肾小球滤过率(GFR)下降是重要的心血管危险因素,但估计的GFR(eGFR)可能会有所不同,具体取决于它是基于肌酐还是胱抑素C。肌酐/胱抑素C组合方程最近显示出最佳估计GFR ;然而,在常规临床护理中使用组合方程式进行风险预测的好处尚未得到研究。这项研究使用可追溯至国际的分析方法,分别比较了肌酐/半胱氨酸蛋白酶抑制剂C组合(CKD-EPI),唯一肌酐方程(CKD-EPI)和唯一胱抑素C方程(CAPA)通过eGFR预测的死亡风险校准器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号